Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -19.38%258M | -24.44%578M | -27.60%320M | -5.79%765M | 12.18%442M | 11.08%812M | 39.72%394M | 44.75%731M | 46.11%282M | -49.80%505M |
| Operating income | -19.38%258M | -24.44%578M | -27.60%320M | -5.79%765M | 12.18%442M | 11.08%812M | 39.72%394M | 44.75%731M | 46.11%282M | -49.80%505M |
| Cost of sales | 17.00%-205M | 24.79%-446M | 30.42%-247M | 16.36%-593M | -7.90%-355M | -16.23%-709M | -40.00%-329M | -35.25%-610M | -40.72%-235M | 45.47%-451M |
| Operating expenses | 17.00%-205M | 24.79%-446M | 30.42%-247M | 16.36%-593M | -7.90%-355M | -16.23%-709M | -40.00%-329M | -35.25%-610M | -40.72%-235M | 45.47%-451M |
| Gross profit | -27.40%53M | -23.26%132M | -16.09%73M | 66.99%172M | 33.85%87M | -14.88%103M | 38.30%65M | 124.07%121M | 80.77%47M | -69.83%54M |
| Selling expenses | 35.71%-9M | -26.32%-24M | -55.56%-14M | 17.39%-19M | -50.00%-9M | -15.00%-23M | -20.00%-6M | -150.00%-20M | 0.00%-5M | 33.33%-8M |
| Administrative expenses | 18.80%-108M | 4.15%-254M | -0.76%-133M | -6.00%-265M | -8.20%-132M | -10.13%-250M | -17.31%-122M | -2.71%-227M | 7.96%-104M | 15.33%-221M |
| Revaluation surplus | ---- | 80.68%-17M | ---- | ---88M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of investment property | ---- | 80.68%-17M | ---- | ---88M | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | ---- | 55.64%-118M | ---- | ---266M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | 55.64%-118M | ---- | ---266M | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%-32M | 15.79%-64M | 27.27%-32M | 19.15%-76M |
| Special items of operating profit | -147.22%-89M | -118.18%-2M | -460.00%-36M | 105.02%11M | -86.84%10M | 33.64%-219M | 590.91%76M | 23.61%-330M | 109.82%11M | -21,500.00%-432M |
| Operating profit | -39.09%-153M | 37.80%-283M | -150.00%-110M | -16.97%-455M | -131.58%-44M | 25.19%-389M | 77.11%-19M | 23.87%-520M | 66.53%-83M | -259.47%-683M |
| Financing cost | 0.00%-57M | 6.45%-116M | -7.55%-57M | -58.97%-124M | ---53M | ---78M | ---- | ---- | ---- | ---- |
| Share of profits of associates | ---- | -25.00%3M | --2M | --4M | ---- | ---- | ---- | 0.00%-1M | ---1M | 50.00%-1M |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -216.67%-14M |
| Earning before tax | -27.27%-210M | 31.13%-396M | -70.10%-165M | -23.13%-575M | -410.53%-97M | 10.36%-467M | 77.38%-19M | 25.36%-521M | 68.30%-84M | -287.78%-698M |
| Tax | ---- | ---- | ---1M | ---- | ---- | ---- | ---- | ---- | ---- | -90.00%5M |
| After-tax profit from continuing operations | -26.51%-210M | 31.13%-396M | -71.13%-166M | -23.13%-575M | -410.53%-97M | 10.36%-467M | 77.38%-19M | 24.82%-521M | 68.30%-84M | -433.08%-693M |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 72.73%-3M |
| Earning after tax | -26.51%-210M | 31.13%-396M | -71.13%-166M | -23.13%-575M | -410.53%-97M | 10.36%-467M | 77.38%-19M | 25.14%-521M | 68.54%-84M | -393.62%-696M |
| Minority shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---7M |
| Minority profit | ---- | ---- | ---- | 200.00%2M | 200.00%2M | 50.00%-2M | 0.00%-2M | 42.86%-4M | 71.43%-2M | ---7M |
| Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -427.69%-686M |
| Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 72.73%-3M |
| Profit attributable to shareholders | -26.51%-210M | 31.37%-396M | -67.68%-166M | -24.09%-577M | -482.35%-99M | 10.06%-465M | 79.27%-17M | 24.96%-517M | 68.46%-82M | -388.65%-689M |
| Basic earnings per share | -26.92%-0.132 | 41.86%-0.25 | -10.64%-0.104 | 18.87%-0.43 | -370.00%-0.094 | 10.17%-0.53 | -121.28%-0.02 | 25.32%-0.59 | 131.54%0.094 | -393.75%-0.79 |
| Diluted earnings per share | -26.92%-0.132 | 41.86%-0.25 | -10.64%-0.104 | 18.87%-0.43 | -370.00%-0.094 | 10.17%-0.53 | -121.28%-0.02 | 25.32%-0.59 | 131.54%0.094 | -393.75%-0.79 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | -- | -- | -- | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.